10x Genomics (TXG) Current Assets (2018 - 2026)

10x Genomics has disclosed Current Assets across 9 years of filings, most recently posting $674.7 million for Q2 2026.

• In Q2 2026, Current Assets rose 2.9% year-over-year to $674.7 million; the TTM figure through Jun 2026 stood at $674.7 million (up 2.9% YoY), while the FY2025 annual figure was $684.5 million, up 17.12% from the prior year.
• Current Assets came in at $674.7 million for Q2 2026 at 10x Genomics, up from $669.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $697.3 million in Q1 2022 to a low of $562.3 million in Q3 2023.
• Average Current Assets over 5 years is $623.3 million, with a median of $615.7 million recorded in 2022.
• Year-over-year, Current Assets dropped 15.41% in 2022 and gained 17.12% in 2025.
• Over 5 years, Current Assets stood at $635.0 million in 2022, then decreased by 6.14% to $596.0 million in 2023, then slipped by 1.95% to $584.4 million in 2024, then grew by 17.12% to $684.5 million in 2025, then declined by 1.43% to $674.7 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $674.7 million in Q2 2026, $669.7 million in Q1 2026, and $684.5 million in Q4 2025.